Respiratory syncytial virus infection: An innate perspective

F1000Research

Volumn 5, Issue , 2016, Pages

  Johansson, Cecilia ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Immune response to RSV; Immune mediated virus clearance; Immunopathology; Lower respiratory disease; Respiratory syncytial virus; RSV

Indexed keywords

RESPIRATORY SYNCYTIAL VIRUS VACCINE;

ADAPTIVE IMMUNITY; HUMAN; IMMUNOPATHOLOGY; INNATE IMMUNITY; NONHUMAN; RESPIRATORY SYNCYTIAL VIRUS INFECTION; REVIEW; VIRAL CLEARANCE; VIRUS IMMUNITY;

EID: 85010874815     PISSN: 20461402     EISSN: 1759796X     Source Type: Journal    
DOI: 10.12688/f1000research.9637.1     Document Type: Review

References (119)

1. Meissner HC: Viral Bronchiolitis in Children. N Engl J Med. 2016;374(1):62-72. 26735994 10.1056/NEJMra1413456
2. Blanken MO Rovers MM Molenaar JM: Respiratory syncytial virus and recurrent wheeze in healthy preterm infants. N Engl J Med. 2013;368(19):1791-9. 23656644 10.1056/NEJMoa1211917
3. Sigurs N Aljassim F Kjellman B: Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax. 2010;65(12):1045-52. 20581410 10.1136/thx.2009.121582
4. Hervás D Reina J Yañez A: Epidemiology of hospitalization for acute bronchiolitis in children: differences between RSV and non-RSV bronchiolitis. Eur J Clin Microbiol Infect Dis. 2012;31(8):1975-81. 22240853 10.1007/s10096-011-1529-y
5. Murray J Bottle A Sharland M: Risk factors for hospital admission with RSV bronchiolitis in England: a population-based birth cohort study. PLoS One. 2014;9(2):e89186. 24586581 10.1371/journal.pone.0089186 3935842
6. Borchers AT Chang C Gershwin ME: Respiratory syncytial virus--a comprehensive review. Clin Rev Allergy Immunol. 2013;45(3):331-79. 23575961 10.1007/s12016-013-8368-9
7. Collins PL Karron RA: Fields Virology. 6 ed. Knipe DM, Howley PM, editors. Lippincott Williams & Wilkins;2013; 1:38.
8. Afonso CL Amarasinghe GK Bányai K: Taxonomy of the order Mononegavirales: update 2016. Arch Virol. 2016;161(8):2351-60. 27216929 10.1007/s00705-016-2880-1 4947412
9. Blount RE Jr Morris JA Savage RE: Recovery of cytopathogenic agent from chimpanzees with coryza. Proc Soc Exp Biol Med. 1956;92(3):544-9. 13359460
10. Chanock R Roizman B Myers R: Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). I. Isolation, properties and characterization. Am J Hyg. 1957;66(3):281-90. 13478578
11. Nair H Nokes DJ Gessner BD: Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010;375(9725):1545-55. 20399493 10.1016/S0140-6736(10)60206-1 2864404
12. Krzyzaniak MA Zumstein MT Gerez JA: Host cell entry of respiratory syncytial virus involves macropinocytosis followed by proteolytic activation of the F protein. PLoS Pathog. 2013;9(4):e1003309. 23593008 10.1371/journal.ppat.1003309 3623752
13. Tayyari F Marchant D Moraes TJ: Identification of nucleolin as a cellular receptor for human respiratory syncytial virus. Nat Med. 2011;17(9):1132-5. 21841784 10.1038/nm.2444
14. Chirkova T Lin S Oomens AG: CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells. J Gen Virol. 2015;96(9):2543-56. 26297201 10.1099/vir.0.000218 4635495
15. Johnson SM McNally BA Ioannidis I: Respiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures. PLoS Pathog. 2015;11(12):e1005318. 26658574 10.1371/journal.ppat.1005318 4676609
16. Jeong K Piepenhagen PA Kishko M: CX3CR1 Is Expressed in Differentiated Human Ciliated Airway Cells and Co-Localizes with Respiratory Syncytial Virus on Cilia in a G Protein-Dependent Manner. PLoS One. 2015;10(6):e0130517. 26107373 10.1371/journal.pone.0130517 4479564
17. Chirkova T Boyoglu-Barnum S Gaston KA: Respiratory syncytial virus G protein CX3C motif impairs human airway epithelial and immune cell responses. J Virol. 2013;87(24):13466-79. 24089561 10.1128/JVI.01741-13 3838285
18. Tripp RA Jones LP Haynes LM: CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein. Nat Immunol. 2001;2(8):732-8. 11477410 10.1038/90675
19. DeVincenzo JP Wilkinson T Vaishnaw A: Viral load drives disease in humans experimentally infected with respiratory syncytial virus. Am J Respir Crit Care Med. 2010;182(10):1305-14. 20622030 10.1164/rccm.201002-0221OC 3001267
20. El Saleeby CM Bush AJ Harrison LM: Respiratory syncytial virus load, viral dynamics, and disease severity in previously healthy naturally infected children. J Infect Dis. 2011;204(7):996-1002. 21881113 10.1093/infdis/jir494 3203391
21. DeVincenzo JP El Saleeby CM Bush AJ: Respiratory syncytial virus load predicts disease severity in previously healthy infants. J Infect Dis. 2005;191(11):1861-8. 15871119 10.1086/430008
22. Houben ML Coenjaerts FE Rossen JW: Disease severity and viral load are correlated in infants with primary respiratory syncytial virus infection in the community. J Med Virol. 2010;82(7):1266-71. 20513094 10.1002/jmv.21771
23. Scagnolari C Midulla F Selvaggi C: Evaluation of viral load in infants hospitalized with bronchiolitis caused by respiratory syncytial virus. Med Microbiol Immunol. 2012;201(3):311-7. 22406873 10.1007/s00430-012-0233-6
24. Goritzka M Makris S Kausar F: Alveolar macrophage-derived type I interferons orchestrate innate immunity to RSV through recruitment of antiviral monocytes. J Exp Med. 2015;212(5):699-714. 25897172 10.1084/jem.20140825 4419339
25. Goritzka M Durant LR Pereira C: Alpha/beta interferon receptor signaling amplifies early proinflammatory cytokine production in the lung during respiratory syncytial virus infection. J Virol. 2014;88(11):6128-36. 24648449 10.1128/JVI.00333-14 4093897
26. Bhoj VG Sun Q Bhoj EJ: MAVS and MyD88 are essential for innate immunity but not cytotoxic T lymphocyte response against respiratory syncytial virus. Proc Natl Acad Sci U S A. 2008;105(37):14046-51. 18780793 10.1073/pnas.0804717105 2532974
27. Falsey AR McElhaney JE Beran J: Respiratory syncytial virus and other respiratory viral infections in older adults with moderate to severe influenza-like illness. J Infect Dis. 2014;209(12):1873-81. 24482398 10.1093/infdis/jit839 4038137
28. Ruckwardt TJ Morabito KM Graham BS: Determinants of early life immune responses to RSV infection. Curr Opin Virol. 2016;16:151-7. 26986236 10.1016/j.coviro.2016.01.003 4821759
29. Lambert L Sagfors AM Openshaw PJ: Immunity to RSV in Early-Life. Front Immunol. 2014;5:466. 25324843 10.3389/fimmu.2014.00466 4179512
30. Pinti M Appay V Campisi J: Aging of the immune system: Focus on inflammation and vaccination. Eur J Immunol. 2016;46(10):2286-301. 27595500 10.1002/eji.201546178 5156481
31. Meyer KC: The role of immunity and inflammation in lung senescence and susceptibility to infection in the elderly. Semin Respir Crit Care Med. 2010;31(5):561-74. 20941657 10.1055/s-0030-1265897
32. Zanin M Baviskar P Webster R: The Interaction between Respiratory Pathogens and Mucus. Cell Host Microbe. 2016;19(2):159-68. 26867175 10.1016/j.chom.2016.01.001 4752725
33. Currie SM Gwyer Findlay E McFarlane AJ: Cathelicidins Have Direct Antiviral Activity against Respiratory Syncytial Virus In Vitro and Protective Function In Vivo in Mice and Humans. J Immunol. 2016;196(6):2699-710. 26873992 10.4049/jimmunol.1502478 4777919
34. LeVine AM Gwozdz J Stark J: Surfactant protein-A enhances respiratory syncytial virus clearance in vivo. J Clin Invest. 1999;103(7):1015-21. 10194474 10.1172/JCI5849 408263
35. LeVine AM Elliott J Whitsett JA: Surfactant protein-d enhances phagocytosis and pulmonary clearance of respiratory syncytial virus. Am J Respir Cell Mol Biol. 2004;31(2):193-9. 15016617 10.1165/rcmb.2003-0107OC
36. de Steenhuijsen Piters WA Heinonen S Hasrat R: Nasopharyngeal Microbiota, Host Transcriptome, and Disease Severity in Children with Respiratory Syncytial Virus Infection. Am J Respir Crit Care Med. 2016;194(9):1104-15. 27135599 10.1164/rccm.201602-0220OC 5114450
37. Teo SM Mok D Pham K: The infant nasopharyngeal microbiome impacts severity of lower respiratory infection and risk of asthma development. Cell Host Microbe. 2015;17(5):704-15. 25865368 10.1016/j.chom.2015.03.008 4433433
38. Durbin RK Kotenko SV Durbin JE: Interferon induction and function at the mucosal surface. Immunol Rev. 2013;255(1):25-39. 23947345 10.1111/imr.12101
39. McNab F Mayer-Barber K Sher A: Type I interferons in infectious disease. Nat Rev Immunol. 2015;15(2):87-103. 25614319 10.1038/nri3787
40. van Drunen Littel-van den Hurk S Watkiss ER: Pathogenesis of respiratory syncytial virus. Curr Opin Virol. 2012;2(3):300-5. 22709517 10.1016/j.coviro.2012.01.008
41. Liesman RM Buchholz UJ Luongo CL: RSV-encoded NS2 promotes epithelial cell shedding and distal airway obstruction. J Clin Invest. 2014;124(5):2219-33. 24713657 10.1172/JCI72948 4001550
42. Lifland AW Jung J Alonas E: Human respiratory syncytial virus nucleoprotein and inclusion bodies antagonize the innate immune response mediated by MDA5 and MAVS. J Virol. 2012;86(15):8245-58. 22623778 10.1128/JVI.00215-12 3421640
43. tenOever BR: RNA viruses and the host microRNA machinery. Nat Rev Microbiol. 2013;11(3):169-80. 23411862 10.1038/nrmicro2971
44. Aguado LC Schmid S Sachs D: microRNA Function Is Limited to Cytokine Control in the Acute Response to Virus Infection. Cell Host Microbe. 2015;18(6):714-22. 26651947 10.1016/j.chom.2015.11.003 4683400
45. Janssen R Bont L Siezen CL: Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes. J Infect Dis. 2007;196(6):826-34. 17703412 10.1086/520886
46. Siezen CL Bont L Hodemaekers HM: Genetic susceptibility to respiratory syncytial virus bronchiolitis in preterm children is associated with airway remodeling genes and innate immune genes. Pediatr Infect Dis J. 2009;28(4):333-5. 19258923 10.1097/INF.0b013e31818e2aa9
47. Marr N Wang TI Kam SH: Attenuation of respiratory syncytial virus-induced and RIG-I-dependent type I IFN responses in human neonates and very young children. J Immunol. 2014;192(3):948-57. 24391215 10.4049/jimmunol.1302007
48. Cormier SA Shrestha B Saravia J: Limited type I interferons and plasmacytoid dendritic cells during neonatal respiratory syncytial virus infection permit immunopathogenesis upon reinfection. J Virol. 2014;88(16):9350-60. 24920801 10.1128/JVI.00818-14 4136292
49. Remot A Descamps D Jouneau L: Flt3 ligand improves the innate response to respiratory syncytial virus and limits lung disease upon RSV reexposure in neonate mice. Eur J Immunol. 2016;46(4):874-84. 26681580 10.1002/eji.201545929
50. Tabarani CM Bonville CA Suryadevara M: Novel inflammatory markers, clinical risk factors and virus type associated with severe respiratory syncytial virus infection. Pediatr Infect Dis J. 2013;32(12):e437-42. 23804121 10.1097/INF.0b013e3182a14407 3883981
51. Demoor T Petersen BC Morris S: IPS-1 signaling has a nonredundant role in mediating antiviral responses and the clearance of respiratory syncytial virus. J Immunol. 2012;189(12):5942-53. 23136205 10.4049/jimmunol.1201763 3888965
52. Makris S Bajorek M Culley FJ: Alveolar Macrophages Can Control Respiratory Syncytial Virus Infection in the Absence of Type I Interferons. J Innate Immun. 2016;8(5):452-63. 27423203 10.1159/000446824
53. Sun Y Jain D Koziol-White CJ: Immunostimulatory Defective Viral Genomes from Respiratory Syncytial Virus Promote a Strong Innate Antiviral Response during Infection in Mice and Humans. PLoS Pathog. 2015;11(9):e1005122. 26336095 10.1371/journal.ppat.1005122 4559413
54. Marr N Turvey SE Grandvaux N: Pathogen recognition receptor crosstalk in respiratory syncytial virus sensing: a host and cell type perspective. Trends Microbiol. 2013;21(11):568-74. 24119913 10.1016/j.tim.2013.08.006 4848032
55. Kim TH Lee HK: Innate immune recognition of respiratory syncytial virus infection. BMB Rep. 2014;47(4):184-91. 24568879 10.5483/BMBRep.2014.47.4.050 4163887
56. Kurt-Jones EA Popova L Kwinn L: Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol. 2000;1(5):398-401. 11062499 10.1038/80833
57. Tal G Mandelberg A Dalal I: Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease. J Infect Dis. 2004;189(11):2057-63. 15143473 10.1086/420830
58. Awomoyi AA Rallabhandi P Pollin TI: Association of TLR4 polymorphisms with symptomatic respiratory syncytial virus infection in high-risk infants and young children. J Immunol. 2007;179(5):3171-7. 17709532 10.4049/jimmunol.179.5.3171
59. Tulic MK Hurrelbrink RJ Prele CM: TLR4 polymorphisms mediate impaired responses to respiratory syncytial virus and lipopolysaccharide. J Immunol. 2007;179(1):132-40. 17579031 10.4049/jimmunol.179.1.132
60. Haynes LM Moore DD Kurt-Jones EA: Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus. J Virol. 2001;75(22):10730-7. 11602714 10.1128/JVI.75.22.10730-10737.2001 114654
61. Ehl S Bischoff R Ostler T: The role of Toll-like receptor 4 versus interleukin-12 in immunity to respiratory syncytial virus. Eur J Immunol. 2004;34(4):1146-53. 15048726 10.1002/eji.200324449
62. Caballero MT Serra ME Acosta PL: TLR4 genotype and environmental LPS mediate RSV bronchiolitis through Th2 polarization. J Clin Invest. 2015;125(2):571-82. 25555213 10.1172/JCI75183 4319428
63. Goritzka M Pereira C Makris S: T cell responses are elicited against Respiratory Syncytial Virus in the absence of signalling through TLRs, RLRs and IL-1R/IL-18R. Sci Rep. 2015;5: 18533. 26688048 10.1038/srep18533 4685246
64. Zelenay S Reis e Sousa C: Adaptive immunity after cell death. Trends Immunol. 2013;34(7):329-35. 23608152 10.1016/j.it.2013.03.005
65. Hosakote YM Brasier AR Casola A: Respiratory Syncytial Virus Infection Triggers Epithelial HMGB1 Release as a Damage-Associated Molecular Pattern Promoting a Monocytic Inflammatory Response. J Virol. 2016;90(21):9618-31. 27535058 10.1128/JVI.01279-16 5068515
66. Foronjy RF Ochieng PO Salathe MA: Protein tyrosine phosphatase 1B negatively regulates S100A9-mediated lung damage during respiratory syncytial virus exacerbations. Mucosal Immunol. 2016;9(5):1317-29. 26813343 10.1038/mi.2015.138 4963308
67. Lay MK Bueno SM Gálvez N: New insights on the viral and host factors contributing to the airway pathogenesis caused by the respiratory syncytial virus. Crit Rev Microbiol. 2016;42(5):800-12. 26119025 10.3109/1040841X.2015.1055711
68. Saravia J You D Shrestha B: Respiratory Syncytial Virus Disease Is Mediated by Age-Variable IL-33. PLoS Pathog. 2015;11(10):e1005217. 26473724 10.1371/journal.ppat.1005217 4608776
69. McNamara PS Ritson P Selby A: Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis. Arch Dis Child. 2003;88(10):922-6. 14500316 10.1136/adc.88.10.922 1719332
70. Kim CK Chung CY Choi SJ: Bronchoalveolar lavage cellular composition in acute asthma and acute bronchiolitis. J Pediatr. 2000;137(4):517-22. 11035831 10.1067/mpd.2000.108392
71. Everard ML Swarbrick A Wrightham M: Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection. Arch Dis Child. 1994;71(5):428-32. 7826113 10.1136/adc.71.5.428 1030058
72. Geerdink RJ Pillay J Meyaard L: Neutrophils in respiratory syncytial virus infection: A target for asthma prevention. J Allergy Clin Immunol. 2015;136(4):838-47. 26277597 10.1016/j.jaci.2015.06.034
73. Funchal GA Jaeger N Czepielewski RS: Respiratory syncytial virus fusion protein promotes TLR-4-dependent neutrophil extracellular trap formation by human neutrophils. PLoS One. 2015;10(4):e0124082. 25856628 10.1371/journal.pone.0124082 4391750
74. Cortjens B de Boer OJ de Jong R: Neutrophil extracellular traps cause airway obstruction during respiratory syncytial virus disease. J Pathol. 2016;238(3):401-11. 26468056 10.1002/path.4660
75. McNamara PS Flanagan BF Hart CA: Production of chemokines in the lungs of infants with severe respiratory syncytial virus bronchiolitis. J Infect Dis. 2005;191(8):1225-32. 15776367 10.1086/428855
76. Bertrand P Lay MK Piedimonte G: Elevated IL-3 and IL-12p40 levels in the lower airway of infants with RSV-induced bronchiolitis correlate with recurrent wheezing. Cytokine. 2015;76(2):417-23. 26299549 10.1016/j.cyto.2015.07.017
77. Davidson S Crotta S McCabe TM: Pathogenic potential of interferon αβ in acute influenza infection. Nat Commun. 2014;5: 3864. 24844667 10.1038/ncomms4864 4033792
78. Herold S Steinmueller M von Wulffen W: Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand. J Exp Med. 2008;205(13):3065-77. 19064696 10.1084/jem.20080201 2605231
79. Hussell T Openshaw PJ: Intracellular IFN-gamma expression in natural killer cells precedes lung CD8+ T cell recruitment during respiratory syncytial virus infection. J Gen Virol. 1998;79(Pt 11):2593-601. 9820134 10.1099/0022-1317-79-11-2593
80. Harker JA Godlee A Wahlsten JL: Interleukin 18 coexpression during respiratory syncytial virus infection results in enhanced disease mediated by natural killer cells. J Virol. 2010;84(8):4073-82. 20130064 10.1128/JVI.02014-09 2849516
81. Meng J Stobart CC Hotard AL: An overview of respiratory syncytial virus. PLoS Pathog. 2014;10(4):e1004016. 24763387 10.1371/journal.ppat.1004016 3999198
82. Neyt K Lambrecht BN: The role of lung dendritic cell subsets in immunity to respiratory viruses. Immunol Rev. 2013;255(1):57-67. 23947347 10.1111/imr.12100
83. Iwasaki A Medzhitov R: Control of adaptive immunity by the innate immune system. Nat Immunol. 2015;16(4):343-53. 25789684 10.1038/ni.3123 4507498
84. Roux X Remot A Petit-Camurdan A: Neonatal lung immune responses show a shift of cytokines and transcription factors toward Th2 and a deficit in conventional and plasmacytoid dendritic cells. Eur J Immunol. 2011;41(10):2852-61. 21770043 10.1002/eji.201041224
85. Ruckwardt TJ Malloy AM Morabito KM: Quantitative and qualitative deficits in neonatal lung-migratory dendritic cells impact the generation of the CD8+ T cell response. PLoS Pathog. 2014;10(2):e1003934. 24550729 10.1371/journal.ppat.1003934 3923758
86. Kerrin A Fitch P Errington C: Differential lower airway dendritic cell patterns may reveal distinct endotypes of RSV bronchiolitis. Thorax. 2016; pii: thoraxjnl-2015-207358. 27531529 10.1136/thoraxjnl-2015-207358
87. Falsey AR Singh HK Walsh EE: Serum antibody decay in adults following natural respiratory syncytial virus infection. J Med Virol. 2006;78(11):1493-7. 16998887 10.1002/jmv.20724
88. Chiu C Openshaw PJ: Antiviral B cell and T cell immunity in the lungs. Nat Immunol. 2015;16(1):18-26. 25521681 10.1038/ni.3056
89. Habibi MS Jozwik A Makris S: Impaired Antibody-mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial Virus. Am J Respir Crit Care Med. 2015;191(9):1040-9. 25730467 10.1164/rccm.201412-2256OC 4435460
90. Vissers M Ahout IM de Jonge MI: Mucosal IgG Levels Correlate Better with Respiratory Syncytial Virus Load and Inflammation than Plasma IgG Levels. Clin Vaccine Immunol. 2015;23(3):243-5. 26656116 10.1128/CVI.00590-15 4783421
91. Jacobino SR Nederend M Hennus M: Human amniotic fluid antibodies protect the neonate against respiratory syncytial virus infection. J Allergy Clin Immunol. 2016;138(5):1477-1480.e5. 27448445 10.1016/j.jaci.2016.06.001
92. Graham BS Bunton LA Wright PF: Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J Clin Invest. 1991;88(3):1026-33. 1909350 10.1172/JCI115362 295511
93. Openshaw PJ Chiu C: Protective and dysregulated T cell immunity in RSV infection. Curr Opin Virol. 2013;3(4):468-74. 23806514 10.1016/j.coviro.2013.05.005 4295022
94. Legg JP Hussain IR Warner JA: Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med. 2003;168(6):633-9. 12773328 10.1164/rccm.200210-1148OC
95. Christiaansen AF Knudson CJ Weiss KA: The CD4 T cell response to respiratory syncytial virus infection. Immunol Res. 2014;59(1-3):109-17. 24838148 10.1007/s12026-014-8540-1
96. Mangodt TC van Herck MA Nullens S: The role of Th17 and Treg responses in the pathogenesis of RSV infection. Pediatr Res. 2015;78(5):483-91. 26267154 10.1038/pr.2015.143
97. Park CO Kupper TS: The emerging role of resident memory T cells in protective immunity and inflammatory disease. Nat Med. 2015;21(7):688-97. 26121195 10.1038/nm.3883 4640452
98. Schenkel JM Masopust D: Tissue-resident memory T cells. Immunity. 2014;41(6):886-97. 25526304 10.1016/j.immuni.2014.12.007 4276131
99. Knudson CJ Weiss KA Hartwig SM: The pulmonary localization of virus-specific T lymphocytes is governed by the tissue tropism of infection. J Virol. 2014;88(16):9010-6. 24899187 10.1128/JVI.00329-14 4136240
100. Jozwik A Habibi MS Paras A: RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection. Nat Commun. 2015;6: 10224. 26687547 10.1038/ncomms10224 4703893
101. Sun L Cornell TT Levine A: Dual role of interleukin-10 in the regulation of respiratory syncitial virus (RSV)-induced lung inflammation. Clin Exp Immunol. 2013;172(2):263-79. 23574323 10.1111/cei.12059 3628329
102. Weiss KA Christiaansen AF Fulton RB: Multiple CD4 + T cell subsets produce immunomodulatory IL-10 during respiratory syncytial virus infection. J Immunol. 2011;187(6):3145-54. 21844390 10.4049/jimmunol.1100764 3304096
103. Sun J Cardani A Sharma AK: Autocrine regulation of pulmonary inflammation by effector T-cell derived IL-10 during infection with respiratory syncytial virus. PLoS Pathog. 2011;7(8):e1002173. 21829368 10.1371/journal.ppat.1002173 3150291
104. Loebbermann J Schnoeller C Thornton H: IL-10 regulates viral lung immunopathology during acute respiratory syncytial virus infection in mice. PLoS One. 2012;7(2):e32371. 22393401 10.1371/journal.pone.0032371 3290561
105. Ouyang W Rutz S Crellin NK: Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol. 2011;29:71-109. 21166540 10.1146/annurev-immunol-031210-101312
106. Loebbermann J Durant L Thornton H: Defective immunoregulation in RSV vaccine-augmented viral lung disease restored by selective chemoattraction of regulatory T cells. Proc Natl Acad Sci U S A. 2013;110(8):2987-92. 23382205 10.1073/pnas.1217580110 3581918
107. Loebbermann J Thornton H Durant L: Regulatory T cells expressing granzyme B play a critical role in controlling lung inflammation during acute viral infection. Mucosal Immunol. 2012;5(2):161-72. 22236998 10.1038/mi.2011.62 3282434
108. Nagata DE Ting H Cavassani KA: Epigenetic control of Foxp3 by SMYD3 H3K4 histone methyltransferase controls iTreg development and regulates pathogenic T-cell responses during pulmonary viral infection. Mucosal Immunol. 2015;8(5):1131-43. 25669152 10.1038/mi.2015.4 4532649
109. Lee DC Harker JA Tregoning JS: CD25 + natural regulatory T cells are critical in limiting innate and adaptive immunity and resolving disease following respiratory syncytial virus infection. J Virol. 2010;84(17):8790-8. 20573822 10.1128/JVI.00796-10 2919030
110. Fulton RB Meyerholz DK Varga SM: Foxp3 + CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytial virus infection. J Immunol. 2010;185(4):2382-92. 20639494 10.4049/jimmunol.1000423 2923480
111. Ruckwardt TJ Bonaparte KL Nason MC: Regulatory T cells promote early influx of CD8 + T cells in the lungs of respiratory syncytial virus-infected mice and diminish immunodominance disparities. J Virol. 2009;83(7):3019-28. 19153229 10.1128/JVI.00036-09 2655550
112. Durant LR Makris S Voorburg CM: Regulatory T cells prevent Th2 immune responses and pulmonary eosinophilia during respiratory syncytial virus infection in mice. J Virol. 2013;87(20):10946-54. 23926350 10.1128/JVI.01295-13 3807299
113. Mazur NI Martinón-Torres F Baraldi E: Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics. Lancet Respir Med. 2015;3(11):888-900. 26411809 10.1016/S2213-2600(15)00255-6
114. Kim HW Canchola JG Brandt CD: Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol. 1969;89(4):422-34. 4305198
115. Karron RA Luongo C Thumar B: A gene deletion that up-regulates viral gene expression yields an attenuated RSV vaccine with improved antibody responses in children. Sci Transl Med. 2015;7(312):312ra175. 26537255 10.1126/scitranslmed.aac8463
116. Graham BS Modjarrad K McLellan JS: Novel antigens for RSV vaccines. Curr Opin Immunol. 2015;35:30-8. 26070108 10.1016/j.coi.2015.04.005 4553118
117. The IMpact-RSV Study Group: Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants. Pediatrics. 1998;102(3):531-7. 9724660 10.1542/peds.102.3.531
118. Boyoglu-Barnum S Todd SO Chirkova T: An anti-G protein monoclonal antibody treats RSV disease more effectively than an anti-F monoclonal antibody in BALB/c mice. Virology. 2015;483:117-25. 25965801 10.1016/j.virol.2015.02.035 4516680
119. Saso A Kampmann B: Vaccination against respiratory syncytial virus in pregnancy: a suitable tool to combat global infant morbidity and mortality? Lancet Infect Dis. 2016;16(8):e153-63. 27317449 10.1016/S1473-3099(16)00119-5